A drug price is only part of the comparison
Semaglutide is an ingredient in Ozempic and Wegovy; tirzepatide is an ingredient in Mounjaro and Zepbound. These medicines are examples from weight or diabetes care.
Drug companies offer prices for people paying for these medicines themselves, outside insurance.
Most of those advertised prices were $149 to $499 per month on September 26, 2026.
The choice of product and how much medicine it contains affect the price; some offers start at an introductory price.
Some prices are higher if a refill falls outside the offer’s time window.
For one company, a monthly price can mean pens sold by the box or tablets sold by the bottle; for another, it means a 28-day supply.
Ask how many days and which package the quoted price covers.
Those prices cover the medicine; they do not quote the cost of an Austin visit.
At some national online weight-care services, the monthly membership price does not include medicine, as of September 26, 2026.
Those are online service fees, not prices for visits in Austin.
Ask whether tests, follow-up visits, supplies, or delivery add to the total.
What to put in a written estimate
- The care fee
- What does the visit or membership cover? What is billed again?
- The medicine
- What product and supply does this price cover? What is the later refill price?
- Tests and other charges
- Which tests are proposed? What else could be charged separately?
- Leaving the plan
- When can I cancel? Is there a commitment or a refund rule?
Insurance needs its own answer
Ask your plan about coverage, naming the medicine exactly and explaining why it would be prescribed.
The list of medicines covered by your plan is called its formulary. Prior authorization means your plan gives its agreement to pay ahead of time.
Medicare Part D is the usual prescription drug coverage. When medicine is used only for weight loss, Part D does not pay, as of September 26, 2026.
For another accepted medical purpose, such as type 2 diabetes treatment, Medicare Part D may pay for the prescription.
The plan must still list the medicine as covered and give any required permission before payment.
A hormone is one of the body’s signals. GLP-1 is a hormone that affects hunger and blood sugar.
Certain weight-loss medicines are part of Medicare’s GLP-1 Bridge, which is a temporary program.
For a month’s supply, people who qualify for this program pay $50 under the rules as of September 26, 2026. The program runs through December 31, 2027.
Only some people qualify, and the program requires a prescription and permission before payment.
For medicines covered by Medicare Part D, your own payments have a yearly limit.
The Bridge’s $50 payments are left out of the Part D yearly payment limit under program rules as of September 26, 2026.
Reaching the Part D limit does not end the separate $50 Bridge payment.
Ask Medicare which payment route applies to your condition and your plan.
Read Medicare’s eligibility and coverage guideRecheck the price before committing
The terms checked on September 26, 2026, said that many prices outside insurance and discount cards would end on December 31, 2026.
That end date leaves the next offer unknown.
What is my full cost now, and what might change at the next refill?
Open the cost and coverage sources
The government price pages list offers for people paying outside insurance. Read who qualifies and when each offer ends. The Medicare pages explain its separate payment program.
Government directory: prices outside insuranceMedicare: temporary program detailsMedicare: who may qualifyKeep this thought
Compare the whole bill for the same product and supply. Keep the later price and cancellation terms beside the opening price.
Know when to pause